Comparison of NB‐UVB combination therapy regimens for vitiligo: A systematic review and network meta‐analysis
Journal of Cosmetic Dermatology · 2023-03 · 22 (3) · 1083-1098
DOI: 10.1111/jocd.15534 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Cosmetic Dermatology, 2022-12. Verfasst von Baohua Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Vitiligo, Ultraviolet Therapy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Development Fund.
Abstract (Originalsprache)
Background
Vitiligo was an autoimmune disease and some guidelines for the management of vitiligo encouraged the use of NB‐UVB combination therapies to enhance repigmentation.
Objectives
To compare the effectiveness of current NB‐UVB combination regimen at the improvement in repigmentation through a systematic review and network meta‐analysis.
Methods
We searched the electronic databases for randomized controlled trials related to NB‐UVB combination therapy for vitiligo till October 2022. STATA15.0 software was applied to carrying out data analysis.
Results
A total of 28 eligible studies involving 1194 participants were enrolled in the analysis. The NMA results revealed that compared with NB‐UVB, carboxytherapy [OR = 32.35, 95% CI (1.79, 586.05)], Er: YAG laser+ topical 5% 5‐FU [OR = 10.74, 95% CI (4.05, 28.49)], needling/micro‐needling [OR = 3.42, 95% CI (1.18, 9.88)], betamethasone intramuscular injection [OR = 3.08, 95% CI (1.17, 8.13)], topical tacrolimus [OR = 2.54, 95% CI (1.30, 4.94)], and oral Chinese herbal medicine compound [OR = 2.51, 95% CI (1.40, 4.50)] integrated with NB‐UVB were more efficacious in excellent to complete repigmentation response rate (≥75%). Besides, NB‐UVB+ Er: YAG laser+ topical 5% 5‐FU [OR = 0.17, 95% CI (0.04, 0.67)] and NB‐UVB+ needling/micro‐needling [OR = 0.24, 95% CI (0.06, 0.88)] were less likely evaluated as ineffective repigmentation response (≤25%).
Conclusions
All combination therapies ranked higher than NB‐UVB monotherapy in inducing successful repigmentation and avoiding failed treatment in patients with vitiligo. Comprehensive consideration, NB‐UVB+ Er: YAG laser+ topical 5% 5‐FU and NB‐UVB+ needling/microneedling would be the preferred therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Department of General Medicine, Affiliated Anqing First People's Hospital of Anhui Medical University, Anqing, China.
- Chengdu Women's and Children's Central Hospital, Chengdu, China.
- Nanjing University of Chinese Medicine, Nanjing, China.
ORCID-Profile: Baohua Zhu
Förderung
- Science and Technology Development Fund
Zitieren
APA
Zhu, B., Liu, C., Zhang, L., Wang, J., Chen, M., & Wei, Y. (2023). Comparison of NB‐UVB combination therapy regimens for vitiligo: A systematic review and network meta‐analysis. Journal of Cosmetic Dermatology, 22(3), 1083-1098. https://doi.org/10.1111/jocd.15534
Vancouver
Zhu B, Liu C, Zhang L, Wang J, Chen M, Wei Y. Comparison of NB‐UVB combination therapy regimens for vitiligo: A systematic review and network meta‐analysis. Journal of Cosmetic Dermatology. 2023;22(3):1083-1098. doi:10.1111/jocd.15534
BibTeX
@article{Zhu2023,
author = {Zhu, Baohua and Liu, Chengjiang and Zhang, Lan and Wang, Jun and Chen, Mingling and Wei, Yuegang},
title = {Comparison of NB‐UVB combination therapy regimens for vitiligo: A systematic review and network meta‐analysis},
journal = {Journal of Cosmetic Dermatology},
year = {2023},
volume = {22},
number = {3},
pages = {1083--1098},
doi = {10.1111/jocd.15534}
}
EUVIMED